Article URL: https://www.kcl.ac.uk/news/hospitals-and-universities-repurposing-drugs-at-90-lower-cost Comments URL: https://news.ycombinator.com/item?id=48583386 Points: 211 # Comments: 86
The increasing pressure on healthcare costs, combined with advancements in molecular understanding and data analysis, makes drug repurposing more attractive and feasible now.
This development highlights a major potential lever for reducing healthcare expenditures and accelerating access to treatments by leveraging existing, safe compounds.
The economics of drug development are potentially altered by demonstrating a viable, significantly cheaper pathway to new treatments, shifting focus from de novo drug discovery.
- · Hospitals
- · Universities and academic research
- · Patients with unmet medical needs
- · Healthcare systems
- · Pharmaceutical companies focused solely on novel drug development
- · Traditional drug discovery pipelines
- · Investors in early-stage novel drug IP
Patients gain access to cheaper therapies for various conditions by using existing drugs for new indications.
Pharmaceutical companies may invest more in drug repurposing divisions or acquire startups specializing in this area, recognizing the market potential.
This could lead to a broader paradigm shift in medical research funding towards 'open science' drug development, emphasizing affordability and accessibility over proprietary new molecules.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at Hacker News — Front Page